课题基金 / 基金详情

A study on the molecular diagnosis of antifolate resistance in leukemia cells : Establishment of anti-folate-resistant cell line and elucidation of molecular mechanisms of resistance

A study on the molecular diagnosis of antifolate resistance in leukemia cells : Establishment of anti-folate-resistant cell line and elucidation of molecular mechanisms of resistance
白血病细胞抗叶酸耐药的分子诊断研究:抗叶酸耐药细胞系的建立及耐药分子机制的阐明
批准号:
07672502
负责人:
MIYACHI Hayato
金额:
$1.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

MIYACHI Hayato的其他基金

相似基金

相关文献

中文摘要
翻译
建立抗叶酸抗性细胞系,以阐明抗叶酸的分子机制。研究了还原或氧化叶酸对甲氨蝶呤(MTX)或N^<10>-丙炔-5,8-二氮杂酚(CB3717)耐酸性的影响。在翼酰基谷氨酸(PGA)中开发的大约60倍MTX耐药CCRF-CEM由于药物的膜转运减少而对MTX耐药。MTX抗性的进一步增强导致选择了大约5000倍的MTX抗性,由于基因扩增而增加了二氢叶酸还原酶(DHFR)。由于基因扩增导致DHFR增加,亚叶酸蛋白中产生了大约140倍和随后1500倍的MTX耐药亚系。大约200倍的cb3717耐药MOLT-3亚系在PGA或亚叶酸钙中开发,减少了膜运输。由于基因扩增,PGA中只有cb3717耐药亚系胸腺苷酸合成酶升高。膜运输缺陷的抗叶酸抗性亚群对三甲氧蝶呤表现出侧枝敏感性,在亚叶酸钙存在下,三甲氧蝶呤敏感性降低,表明对TMQ的侧枝敏感性是由细胞内叶酸缺乏引起的。
英文摘要
Antifolate resistant cell lines were established to elucidate molecular mechanisms of resistance. Effects of reduced or oxidized folates on the development of methotrexate (MTX) or N^<10>-propargyl-5,8-dideazafolic (CB3717) acid resistance were examined. An approximately 60-fold MTX-resistant CCRF-CEM developed in pteroylglutamic acid (PGA) was resistant to MTX by virtue of decreased membrance transport of the drug. Further enhancement of MTX resistance resulted in selection of an approximately 5000-fold MTX resistance as noted by increased dihydrofolate reductase (DHFR) due to gene amplification. An approximately 140-fold and subsequently 1500-fold MTX-resistant subline developed in leucovorin were resistant to MTX by virtue of increased DHFR due to gene amplification. Approximately 200-fold CB3717-resistant MOLT-3 sublines developed in PGA or leucovorin had decreased membrance transport. Only CB3717-resistant subline developed in PGA had increased thymidylate synthase due to gene amplification. Membrane transport defective anti-folate-resistant sublines showed collateral sensitivity to trimeterxate, which was reduced in the presence of leucovorin, suggesting collateral sensitivity to TMQ was caused by intracellular folate defficiency.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Miyachi Hayato,etal: "Amplification of the thymidylate synthase gene in an N^<10>-propargyl-5,8-dideaza folic-acid-resistant human leukemid,MOLT-3 developed in R6A,but notin leu解読不可" J.Cancer Res.Clin.Oncol. 122. 659-664 (1996)
Miyachi Hayato等人:“在N^10-炔丙基-5,8-二脱氮杂叶酸抗性人白血病中扩增胸苷酸合酶基因,MOLT-3是在R6A中开发的,但不是无法破译的亮氨酸”J. Cancer临床研究。122。659-664(1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of an evaluation method based on the elucidation of drug-resistance mechanisms of leukaemia cells through bone marrow niche cross talk
  • 批准号:
    18K07425
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2018
  • 负责人:
    MIYACHI Hayato
  • 依托单位:
Molecular mechanisms of refractory leukemia cells in the bone marrow microenvironment
  • 批准号:
    15K08654
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2015
  • 负责人:
    MIYACHI Hayato
  • 依托单位:
Elucidation of Molecular Mechanisms of Refractory Leukemia: Diagnostic Implications of FLT3-ITD Associated Biomarkers for Drug Resistance.
  • 批准号:
    24590709
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.49万
  • 财政年份:
    2012
  • 负责人:
    MIYACHI Hayato
  • 依托单位:
Elucidation of molecular mechanisms of drug-resistant leukemia through micro RNA analysis : applications to laboratory diagnostics
  • 批准号:
    21590640
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2009
  • 负责人:
    MIYACHI Hayato
  • 依托单位:
国内基金
海外基金
Naringin通过改善Leptin Resistance调节肠上皮AQP3重建糖脂代谢平衡的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    周烨
  • 依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
SMC5-NSMCE2功能异常激活APSCs中p53/p16衰老通路导致脂肪萎缩和胰岛素抵抗的机制研究
  • 批准号:
    82371873
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    乔洁
  • 依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
  • 批准号:
    82372203
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李然然
  • 依托单位: